| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.49 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |